Art. 20 Regulation (EU) 2016/161

Verification of the authenticity of the unique identifier by wholesalers

In forcesince 1 Jan 2022cited 2×

A wholesaler shall verify the authenticity of the unique identifier of at least the following medicinal products in his physical possession:

(a)

medicinal products returned to him by persons authorised or entitled to supply medicinal products to the public or by another wholesaler;

(b)

medicinal products he receives from a wholesaler who is neither the manufacturer nor the wholesaler holding the marketing authorisation nor a wholesaler who is designated by the marketing authorisation holder, by means of a written contract, to store and distribute the products covered by his marketing authorisation on his behalf.

A wholesaler established in Northern Ireland, Cyprus, Ireland or Malta shall perform adequate verifications to ensure that shipments of medicinal products manufactured and labelled for the United Kingdom market comply with the requirement to bear safety features under Article 54a(1) of Directive 2001/83/EC when received from the manufacturer, the marketing authorisation holder or a wholesaler who is designated by the marketing authorisation holder, by means of a written contract, to store and distribute the products covered by his marketing authorisation on his behalf.

  • Opinion of Advocate General Szpunar delivered on 13 January 2022. Novartis Pharma GmbH v Abacus Medicine A/S.Decision

    Last, having regard to all of the foregoing considerations, I propose that the Court answer the questions for a preliminary ruling referred by the Sø – og Handelsretten (Maritime and Commercial Court, Denmark) in Case C‑224/20 as …

    13 Jan 2022 · 62020CC0147

  • Regulation (EU) 2022/315Lawamends